164 studies found for:    "Choroiditis"
Show Display Options
Rank Status Study
1 Recruiting Safety, Tolerability and Efficacy of Intravitreal LFG316 in Patients With Multifocal Choroiditis and Panuveitis (MCP)
Conditions: Multifocal Choroiditis;   Panuveitis;   Active Vitritis
Interventions: Drug: LFG316;   Drug: Conventional Therapy
2 Completed Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
Conditions: Vogt Koyanagi Harada Disease;   Serpiginous Choroiditis;   Multifocal Choroiditis
Interventions: Drug: Bevacizumab;   Procedure: Intravitreal Injection of Bevacizumab
3 Completed Evaluation and Treatment of Patients With Inflammatory Eye Diseases
Conditions: Choroiditis;   Iridocyclitis;   Iritis;   Retinal Disease
Intervention:
4 Completed Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization
Conditions: Neovascularization;   Tuberculosis;   Multifocal Serpiginous Choroiditis;   Harada Toxoplasmosis
Intervention:
5 Withdrawn Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Conditions: Choroidal Neovascularization;   Myopia;   Punctate Inner Choroidopathy (PIC);   Multifocal Choroiditis;   Ocular Histoplasmosis Syndrome;   Central Serous Chorioretinopathy (CSC);   Angioid Streaks;   Trauma, or Hereditary Eye Diseases
Interventions: Drug: Bevacizumab (Avastin; Genentech, Inc.);   Drug: Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy
6 Completed Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
Conditions: Coats' Disease;   Idiopathic Retinal Telangiectasia;   Retinal Angiomatous Proliferation;   Polypoidal Choroidal Vasculopathy;   Pseudoxanthoma Elasticum;   Pathological Myopia;   Multi-focal Choroiditis;   Rubeosis Iridis;   Von Hippel Lindau Disease;   BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)
Intervention: Drug: ranibizumab injection (0.5 mg)
7 Completed Safety and Efficacy of AIN457 in Noninfectious Uveitis
Condition: Active Uveitis That is Not From an Infection.
Interventions: Drug: AIN457 subcutaneous dose;   Drug: AIN457 low dose (i.v);   Drug: AIN457 high dose (i.v)
8 Completed
Has Results
Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis
Condition: Uveitis
Intervention: Drug: Adalimumab
9 Completed
Has Results
Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema
Conditions: Uveitis;   Cystoid Macular Edema
Intervention: Drug: Pegaptanib
10 Unknown  The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis
Conditions: Uveitis;   Arthritis, Juvenile Rheumatoid
Intervention: Drug: TNFR:Fc
11 Completed Research Study in Patients With Persistent Macular Edema
Conditions: Diabetes;   Macular Edema;   Diabetic Retinopathy;   Retinal Disease;   Uveitis, Posterior
Intervention: Drug: DEX PS DDS®
12 Withdrawn Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema
Conditions: Uveitic Macular Edema;   Intraocular Inflammation
Intervention: Drug: Infliximab (intravitreal, 2.0mg/0.05ml)
13 Completed Combination Daclizumab/Denileukin Diftitox to Treat Uveitis
Condition: Non-Infectious Intermediate and Posterior Uveitis
Intervention: Drug: Daclizumab
14 Unknown  Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
Conditions: Uveitis;   Diabetic Retinopathy;   Choroidal Neovascularization
Intervention: Drug: adalimumab
15 Unknown  The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema
Conditions: Uveitis Related Cystoid Macular Edema;   Steroid-induced Glaucoma - Borderline
Intervention: Drug: Ranibizumab
16 Terminated Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular Oedema
Condition: Uveitis
Interventions: Drug: bevacizumab;   Drug: triamcinolone acetonide
17 Recruiting Tissue Studies of Human Eye Diseases
Conditions: Conjunctival Disease;   Corneal Disease;   Eye Disease;   Uveitis;   Vitreoretinopathy, Proliferative
Intervention:
18 Terminated Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis Study
Condition: Non-infectious Uveitis
Interventions: Biological: AIN457;   Drug: Placebo
19 Recruiting PEMF: an Adjunct Therapy for Anterior Uveitis
Conditions: Anterior Uveitis;   Iritis
Interventions: Device: PEMF;   Device: PEMF Placebo
20 Completed A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate;   Panuveitis
Interventions: Drug: Placebo;   Drug: LX211

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years